Failure in Developing Effective Treatment for Cerebral Ischemia: The Stair Recommendations
Journal Title: International Journal of Research in Pharmacy and Science - Year 2011, Vol 1, Issue 1
Abstract
Cerebral ischemia leads to neurological dysfunction and activate complex signalling cascades, which may depreciate survival mechanisms as a result of cellular homeostatic breakdown. For acute ischaemic stroke, safe and effective treatments that offer an extended therapeutic window are urgently needed to decrease disability and aid neurological recovery. The benefit of recombinant tissue-type plasminogen activator (rt-PA) when initiated within 3 hours of stroke onset documents that acute ischemic stroke can indeed respond to treatment. This news is countered by the current lack of documentation that any purported neuroprotective drug significantly improves outcome when given after stroke onset. Lessons have been learned from the innumerable unsuccessful thrombolytic and neuroprotective trials, suggesting that future, better designed trials will likely demonstrate significant benefits with appropriate safe and effective drug treatments initiated within 6 hours of stroke onset. Also, the age of combination drug trials is approaching and combination treatments directed at both the vascular and cellular mechanisms of ischemic brain injury are likely to have the greatest impact upon stroke disability. The apparent failure of neuroprotection for acute ischemic stroke has caused a series of active discussions in both academic and industrial fields, which is fruitful and constructive in attempts to establish criteria for preclinical stroke studies. Since the Stroke Therapy Academic Industry Roundtable (STAIR) published its first criteria in 1999 and updated, quality of study design problems and inflation of reported efficacy of neuroprotectants have continued to be major issues in this field. Translational research of neuroprotection for ischemic stroke has reached its critical stage. A strategic reconsideration is urgently needed to aid in the search for new solutions.
Authors and Affiliations
Binayak Deb, Divya Ramani
Keywords
Related Articles
- EP ID EP124519
- DOI -
- Views 124
- Downloads 0
Antimalarial Activity: A QSAR Modeling of NF54 Strain of Plasmodium falciparum by Physicochemical Descriptor Calculation
Multiple linear regression analysis and other statistical analysis were carried out on all the compounds of training set. Descriptors were selected for the model based on their correlation coefficient and those descripto...
A Specific Study of Drinking Water Status in Term of Essential Characteristics Present in Rural and Urban Area of Alwar District (Raj.), India
Water is a precious commodity and very essential part of human life. We can say that survival oflife can not possible without water and if drinking water has some undesirable substance because ofits good solvent na...
Formulation and Evaluation of Gastroretentive Floating Tablet of Aceclofenac
Tablet can be Utilized for precise delivery of drugs and reduce the drug concentrations at sites other than the target organ. The present study performed by preparation and evaluation of floating tablets of Aceclofenac a...
Transdermal Drug Delivery of Salbutamol Sulphate with Different Concentration of Polymers
Matrix-type transdermal therapeutic system containing salbutamol sulphate was prepared using different polymers by solvent evaporation technique. Seven different formulations of transdermal patch composed of hydrophilic...
An Update on Pharmacological Properties of Cumin
Cumin commonly known as Jeera commonly used in the house hold work as spice. Cumin(Cuminum cyminum) is a flowering plant in the family Apiaceae It is an ancient spice which history dates back to use in Egypt used by...